These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 25182483)

  • 1. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
    Zhang X; Gu B; Mei Y; Wen Y; Xia W
    J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
    Bandy A; Almaeen AH
    PLoS One; 2020; 15(6):e0233704. PubMed ID: 32516308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia.
    Villegas MV; Briceno DF; Ruiz SJ; Furtado GH; Nicolau DP
    Braz J Infect Dis; 2011; 15(5):413-9. PubMed ID: 22230846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
    J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in gram-negative bacilli: a Singapore perspective.
    Tan TY; Hsu LY; Koh TH; Ng LS; Tee NW; Krishnan P; Lin RT; Jureen R
    Ann Acad Med Singap; 2008 Oct; 37(10):819-25. PubMed ID: 19037514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.
    Karakonstantis S; Kritsotakis EI; Gikas A
    Infection; 2020 Dec; 48(6):835-851. PubMed ID: 32875545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistotyping, phenotyping and genotyping of New Delhi metallo-β-lactamase (NDM) among Gram-negative bacilli from Iranian patients.
    Shokri D; Rabbani Khorasgani M; Fatemi SM; Soleimani-Delfan A
    J Med Microbiol; 2017 Apr; 66(4):402-411. PubMed ID: 28150578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics.
    Matsumoto S; Singley CM; Hoover J; Nakamura R; Echols R; Rittenhouse S; Tsuji M; Yamano Y
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First Detection of VIM-4-Producing Pseudomonas aeruginosa and OXA-48-Producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria.
    Mellouk FZ; Bakour S; Meradji S; Al-Bayssari C; Bentakouk MC; Zouyed F; Djahoudi A; Boutefnouchet N; Rolain JM
    Microb Drug Resist; 2017 Apr; 23(3):335-344. PubMed ID: 27314660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
    Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
    Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Urban C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2732-4. PubMed ID: 20368401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii in high complexity hospital.
    Baumgart AM; Molinari MA; Silveira AC
    Braz J Infect Dis; 2010; 14(5):433-6. PubMed ID: 21221469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.
    Perez F; Endimiani A; Ray AJ; Decker BK; Wallace CJ; Hujer KM; Ecker DJ; Adams MD; Toltzis P; Dul MJ; Windau A; Bajaksouzian S; Jacobs MR; Salata RA; Bonomo RA
    J Antimicrob Chemother; 2010 Aug; 65(8):1807-18. PubMed ID: 20513702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
    Landman D; Babu E; Shah N; Kelly P; Olawole O; Bäcker M; Bratu S; Quale J
    J Antimicrob Chemother; 2012 Jun; 67(6):1427-31. PubMed ID: 22378678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.